Peptide Therapy: Promise, Perspective, and Practical Guidance
By Dr. Christopher Lepisto
If you’ve spent any time reading about natural ways to improve athletic performance, lose weight, repair the gut, or reduce joint inflammation, you’ve likely encountered peptide therapy. Peptides are short chains of amino acids—the building blocks of proteins—used in natural or synthetic forms to influence specific body functions.
For someone like Mike, focused on performance and inflammation—or Maureen, considering weight loss and gut health—peptides may be a legitimate consideration for staying active and strong.
Two peptides that may align with a naturopathic approach include Thymosin Alpha-1, studied for its immune-modulating effects, and BPC-157, which shows promise in supporting repair of tendons, ligaments, muscle, and the gut. In my practice, peptides are always considered within the context of each patient’s physiologic foundations.
Beyond the question, “Do peptides work?” a more important one is, “Are they right for me?”
Not all peptides are created equal. In contrast to those naturally derived, pharmaceutical versions can carry significant risks. The most widely prescribed are GLP-1 agonists, originally developed for Type 2 diabetes and now commonly used for weight loss. Their black-box warnings alone warrant thoughtful attention. While I have general concerns about their widespread use, it’s important to distinguish these medications from other peptide therapies.
Another concern is the inconsistent regulation, access, and quality control standards surrounding many peptide products. When appropriate, I provide access to carefully sourced compounded and professional formulations, including IV and oral options—but only after thoughtful evaluation.
Like many trends in performance, weight loss, and inflammation care, peptides will continue to generate attention. My role is to help you navigate these options carefully—balancing potential benefit, risk, and timing—so that any decision supports your long-term vitality, not just short-term momentum.
